Similar articles

• Extracorporeal artificial liver support in hepatic failure: pathfinder, bridge to recovery or dead end street?

  Fuhrmann V, Derfler K, Trauner M. Fuhrmann V, et al. Liver Int. 2011 Sep;31 Suppl 3:iv. doi: 10.1111/j.1478-3231.2011.02581.x. Liver Int. 2011. PMID: 21824273 No abstract available.
• [The opportunities for extracorporeal treatment of hepatic failure].

  Kutepov DE, Pasechnik IN, Sal'nikov PS. Kutepov DE, et al. Khirurgiia (Mosk). 2014;(2):55-8. Khirurgiia (Mosk). 2014. PMID: 24757742 Review. Russian. No abstract available.
• [Individualized artificial liver treatment on patients with liver failure].

  DUAN ZP, ZHANG J. DUAN ZP, et al. Zhonghua Gan Zang Bing Za Zhi. 2009 May;17(5):324-5. Zhonghua Gan Zang Bing Za Zhi. 2009. PMID: 19497191 Chinese. No abstract available.
• Liver support systems: will they ever reach prime time?

  Bañares R, Catalina MV, Vaquero J. Bañares R, et al. Curr Gastroenterol Rep. 2013 Mar;15(3):312. doi: 10.1007/s11894-013-0312-x. Curr Gastroenterol Rep. 2013. PMID: 23392862 Review.
• The 3rd International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI).

  Kellum JA, Bellomo R, Ronco C, Mehta R, Clark W, Levin NW. Kellum JA, et al. Int J Artif Organs. 2005 May;28(5):441-4. doi: 10.1177/039139880502800503. Int J Artif Organs. 2005. PMID: 15883957 No abstract available.